(By Sharon Begley for STAT)
Researchers have cleared the last scientific hurdle to a clinical trial of gene therapy1 to cure sickle cell disease, they reported2 on Tuesday, fueling hopes that they will begin enrolling patients early next year. But they dodged a bullet. Continue reading article here…..
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.